A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel-Reference-Cited by-同舟云学术

A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel

Published:2021-08-18 Issue:9 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Wolk Donna M.¹^ORCID,Young Stephen²,Whitfield Natalie N.³^ORCID,Reid Jennifer L.³,Thornberg Adam³,Carroll Karen C.⁴,Buchan Blake W.⁵^ORCID,Davis Thomas E.⁶,Salimnia Hossein⁷

Affiliation:

1. Geisinger Health, Danville, Pennsylvania, USA

2. TriCore Reference Laboratories, Albuquerque, New Mexico, USA

3. GenMark Diagnostics, Carlsbad, California, USA

4. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

5. Medical College of Wisconsin, Milwaukee, Wisconsin, USA

6. Indiana University, Bloomington, Indiana, USA

7. Detroit Medical Center, Detroit, Michigan, USA

Abstract

Bacteremia can progress to septic shock and death without appropriate medical intervention. Increasing evidence supports the role of molecular diagnostic panels in reducing the clinical impact of these infections through rapid identification of the infecting organism and associated antimicrobial resistance genes.

Funder

GenMark Diagnostics

GenMark Diagnsotics

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.02484-20

Reference64 articles.

1. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations

2. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*